This study consists of a 3-year double-blind phase during which patients will receive atopic
dermatitis (AD) treatment either with pimecrolimus cream 1% long-term management (LTM) or
with a conventional corticosteroid-based treatment (1: 1 ratio), followed by a 2 to 3-year
open-label (OL) phase (all patients receiving pimecrolimus cream 1% LTM). At the end of the
double-blind phase, the two treatment groups will be compared with respect to their efficacy
in controlling AD; at the end of the OL phase, the incidence of asthma at the age of 6 years
will be compared.
Minimum age: 3 Months.
Maximum age: 18 Months.
Gender(s): Both.
Alabama Allergy and Asthma Center, Birmingham, Alabama 35209, United States
Northwest Arkansas Pediatric Clinic, P.A., Fayetteville, Arkansas 72703, United States
The Children's Clinic of Jonesboro, Jonesboro, Arkansas 72401, United States
Southern California Research, Mission Viejo, California 92691, United States
Children's Hospital of Orange County, Orange, California 92868, United States
Stanford Dermatology Clinic and Clinical Trials Dept, Redwood City, California 94063, United States
Capital Allergy Respiratory Disease Center, Sacramento, California 95819, United States
Children's Hospital San Diego, San Diego, California 92123, United States
Allergy and Asthma Medical Group of Diablo Valley, Inc./ Clinical Research Division, Walnut Creek, California 94598, United States
National Jewish Medical and Research Center, Denver, Colorado 80206, United States
Dermatology Associates and Research, Coral Gables, Florida 33134, United States
Emerald Coast Clinical Research, Pensacola, Florida 32503, United States
Children's Memorial Hospital, Chicago, Illinois 60614, United States
Indiana University Outpatient Clinical Research, Indianapolis, Indiana 46202, United States
Central Kentucky Research Associates, Lexington, Kentucky 40509, United States
Dermatology Specialists, Louisville, Kentucky 40202, United States
Rx R & D, Metarie, Louisiana 70002, United States
Johns Hopkins Hospital, Baltimore, Maryland 21287, United States
Children's Hospital - Boston, Boston, Massachusetts 02115, United States
Dermatology, PLLC, Ann Arbor, Michigan 48103, United States
Mayo Clinic Rochester, Rochester, Minnesota 55905, United States
Central Dermatology, St Louis, Missouri 63117, United States
Skin Specialists, P.C., Omaha, Nebraska 68144, United States
Dartmouth-Hitchcock Medical Center/Dermatology Section, Lebanon, New Hampshire 03756, United States
Children's Medical Group, Hopewell Junction, New York 12533, United States
Dermatology Associates of St. Luke's - Roosevelt, New York, New York 10025, United States
Calcagno Research and Development, Gresham, Oregon 97030, United States
Oregon Health Science University - Dermatology Dept., Portland, Oregon 97201, United States
The Childrens' Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, United States
Allegheny General Hospital, Pittsburgh, Pennsylvania 15212, United States
Tennessee Clinical Research Center, Nashville, Tennessee 37215, United States
Texas Children's Hospital, BCM, Houston, Texas 77030, United States
Alpine Medical Group, LLC, Salt Lake City, Utah 84102, United States
Granger Medical Clinic, West Valley City, Utah 84120, United States
Virginia Clinical Research, Norfolk, Virginia 23507, United States
Asthma Inc, Seattle, Washington 98105, United States